Literature DB >> 11818145

The HIV/AIDS vaccine researchers' orientation to the process of preparing a US FDA application for an investigational new drug (IND): what it is all about and how you start by preparing for your pre-IND meeting.

Stuart Z Shapiro1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11818145     DOI： 10.1016/s0264-410x(01)00453-4

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  2 in total

Review 1.  Emerging respiratory viruses: challenges and vaccine strategies.

Authors:  Laura Gillim-Ross; Kanta Subbarao
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

Review 2.  Now that you want to take your HIV/AIDS vaccine/biological product research concept into the clinic: what are the "cGMP"?

Authors:  Rebecca L Sheets; Vijaya Rangavajhula; Jeffrey K Pullen; Chris Butler; Vijay Mehra; Stuart Shapiro; Michael Pensiero
Journal:  Vaccine       Date:  2015-02-16       Impact factor: 3.641
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.